FOLFOX-HAIC for Unresectable Large Hepatocellular Carcinoma: The Effectiveness Has Yet to be Determined

J Clin Oncol. 2022 Jun 1;40(16):1841. doi: 10.1200/JCO.21.02533. Epub 2022 Mar 22.

Authors

Junhao Mei¹, Haiyang Yu¹, Lihao Qin¹, Zhongzhi Jia¹

Affiliation

¹ Junhao Mei, MD, Haiyang Yu, MD, Lihao Qin, MD, and Zhongzhi Jia, PhD, Department of Interventional and Vascular Surgery, No. 2 People's Hospital of Changzhou, Nanjing Medical University, Chang zhou, China.

PMID: 35316092
DOI: 10.1200/JCO.21.02533

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Carcinoma, Hepatocellular* / drug therapy
Chemoembolization, Therapeutic*
Hepatic Artery
Humans
Infusions, Intra-Arterial
Liver Neoplasms* / drug therapy
Treatment Outcome